Device To Improve Venipuncture Accuracy
-
Printer Friendly|#| Trackback
Vein contrast enhancer improves chances you'll get stuck only once:
" "Herbert Zeman has invented a device he calls the vein contrast enhancer (VCE) that is aimed at reducing failed attempts at hitting the vein the first time during blood tests, injections, and IV drip insertions. The device uses infrared LEDs to point out areas of high blood concentration, which, if the patient is in fact human, are veins. The LEDs illuminate the skin at a wavelength of 740 nanometers which is highly-absorbed by blood and dispered by fat and other tissue. The result is an image that represents the location of veins. This image is then projected back onto the skin using a “hot mirror” that ensures accuracy within 0.06mm.""
[Via Engadget]
Iraq Survey Group Report Available
-
Printer Friendly|#| Trackback
The Iraq Survey Group report is available at the CIA website. They've broken out the 'Key Findings' as a separate PDF document. Don't just be content to let some reporter tell you what is says. Go look for yourself...
Harvest of Organs Was 'Homicide'
-
Printer Friendly|#| Trackback
The Australian: Harvest of organs was 'homicide':
""A US coroner issued a homicide finding yesterday after determining that two hospitals allowed vital organs to be removed from a man before they had proven he was brain dead.
William Rardin's cause of death was "removal of his internal organs by an organ recovery team", ruled coroner Mark Young in Montrose County, Colorado.
He said he did not believe the case should be a criminal matter, but suggested it "should lead to a clarification of what the accepted standard is".
Mr Young said the two hospitals did not follow "accepted medical standards" or meet state guidelines in determining that Rardin, 31, was brain dead after he shot himself last month.""
What were the tests done at the hospital to determine brain death? Splashy headline, but we need more facts to really know what went on.
Donor card, anyone?
Brain MRI Successfully Adapted for Intraoperative Use
-
Printer Friendly|#| Trackback
Brain MRI Successfully Adapted for Intraoperative Use in Germany.
A neurosurgeon's wet dream
FDA Public Health Advisory: Safety of Vioxx
-
Printer Friendly|#| Trackback
FDA Public Health Advisory: Safety of Vioxx from the FDA and also a FAQ.
As far as I have been able to find out, the results that led to the early termination of the APPROVe trial have not been published. What seems to have happened is that the trial was terminated because interim analysis revealed the increased risk of heart attacks in those taking Vioxx for more than 18 months. Of note is the fact that the study enrolled fewer than three thousand patients, yet still possessed enough power to allow this conclusion, which suggests to me that complications were not rare (in which case a much larger study sample would have been needed to demonstrate this result).
Vioxx: How Safe Is FDA Approval?
-
Printer Friendly|#| Trackback
Vioxx: How Safe Is FDA Approval?:
""The problems with Vioxx, taken off the market last week, raise questions about the Food and Drug Administration's safety review process. Observers say longer clinical trials should be required.""
[Via Wired News]
Did Kerry Cheat in First Debate?
-
Printer Friendly|#| Trackback
"No props, notes, charts, diagrams, or other writings or other tangible things may be brought into the debate by any candidate." So states the memorandum of understanding between the two campaigns regarding the debates. Yet, this video shows John Kerry taking something out of his pocket at the beginning of the debate and placing it on his lectern. Please explain, Mr. Kerry. Perhaps it was a picture of Teresa to inspire you?
[via American Daughter]
What's Michael Moore Up To?
-
Printer Friendly|#| Trackback
It seems Michael Moore is turning his camera on drug makers and health unsurers.
""Companies have warned their sales representatives to be on the lookout for camera phones and reports of Moore representatives offering $50,000 to doctors' offices to place hidden cameras or $5,000 to sales representatives willing to be filmed, according to a representative of one drug maker, who asked not to be identified.
"Moore's spokesman would not comment on any production activity or allegations of payments to drug company employees.""